UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050467
Receipt number R000057465
Scientific Title A retrospective study of the clinical characteristics of prescription and over-the-counter drug use disorders
Date of disclosure of the study information 2023/03/02
Last modified on 2024/09/16 21:12:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A retrospective study of the clinical characteristics of prescription and over-the-counter drug use disorders

Acronym

A retrospective study of the clinical characteristics of prescription and over-the-counter drug use disorders

Scientific Title

A retrospective study of the clinical characteristics of prescription and over-the-counter drug use disorders

Scientific Title:Acronym

A retrospective study of the clinical characteristics of prescription and over-the-counter drug use disorders

Region

Japan


Condition

Condition

Substance use disorders (prescription and over-the-counter drugs)

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To identify the clinical characteristics of prescription and over-the-counter drug use disorders

Basic objectives2

Others

Basic objectives -Others

To identify the clinical characteristics of prescription and over-the-counter drug use disorders

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To identify the clinical characteristics of prescription and over-the-counter drug use disorders

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Patients with an initial our hospital outpatient visit between January 1, 2016 and December 31, 2022
2)Those who with prescription (hypnotics/anxiolytics) and over-the-counter drugs use disorders

Key exclusion criteria

Those who with defective data

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Toshihiko
Middle name
Last name Matsumoto

Organization

National Center of Neurology and Psychiatry

Division name

Department of Drug Dependence Research

Zip code

187-8551

Address

4-1-1 Ogawa-higashi, Kodaira, Tokyo

TEL

042-341-2711

Email

tmatsu@ncnp.go.jp


Public contact

Name of contact person

1st name Kaori
Middle name
Last name Ishii

Organization

National Center of Neurology and Psychiatry

Division name

Pharmacy

Zip code

187-8551

Address

4-1-1 Ogawa-higashi, Kodaira, Tokyo

TEL

042-341-2711

Homepage URL


Email

yaku.ishii@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

National Center of Neurology and Psychiatry

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board at National Center of Neurology and Psychiatry

Address

4-1-1 Ogawa-higashi, Kodaira, Tokyo

Tel

042-341-2711

Email

rinri-jimu@ncnp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 03 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 02 Month 01 Day

Date of IRB

2023 Year 03 Month 02 Day

Anticipated trial start date

2023 Year 03 Month 02 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry

2024 Year 03 Month 31 Day

Date trial data considered complete


Date analysis concluded



Other

Other related information

Retrospective study


Management information

Registered date

2023 Year 03 Month 02 Day

Last modified on

2024 Year 09 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057465